The World’s First LIVING Brain Prosthetic

NEURON INPUT TO OUTPUT

ni2o is a US-based company working to cure neurodegenerative diseases, like Alzheimer’s, Parkinson’s and ALS, with AI and brain-tech (BCI).

We exist to restore human dignity and ability to those suffering with debilitating brain disorders. Nowhere is this need more critical than Alzheimer’s, where patients and families face an overwhelming burden and the healthcare system strains under unsustainable costs. With the global population of those over 60 expected to more than double by 2050, the challenge is clear: without bold innovation, societies cannot provide the care these patients deserve. ni2o is delivering that innovation to shift Alzheimer’s from inevitable decline to early detection, better management, and ultimately reversal.

We are building a continuum of brain health solutions that starts with prevention and leads to treatment: 1. Ultra-Early Detection (4cyte AI): Proprietary software that identifies signs of Alzheimer’s years before clinical symptoms appear, giving families, physicians, and researchers the ability to act earlier than ever. 2. Continuous Monitoring and Non-Invasive Stimulation (tKIWI): A wearable, EEG-like headcap that records brain activity, supports ongoing monitoring, and enables non-invasive early interventions. 3. Minimally Invasive Therapy (KIWI Micro-Implant): A transformative alternative to today’s high-risk neurosurgical procedures. KIWI is designed as a micro-implant capable of safely restoring brain function, opening the door to treatments that are accessible, scalable, and cost-effective.

Our Focus We begin where the need is greatest: Alzheimer’s disease, a condition with no cure, skyrocketing prevalence, and devastating economic impact. From this foundation, our platform naturally extends to Parkinson’s, ALS, and related neurodegenerative conditions, where patients face similar gaps in early detection, continuous monitoring, and safe therapeutic options.

ni2o is advancing a new paradigm for brain health, starting with Alzheimer’s. Through AI-enabled detection, real-time monitoring, and minimally invasive treatment, our mission is bold but clear: restore the brain, restore the person, restore dignity.